The role of age and cardiovascular disease in glaucomatous optic neuropathy

Survey of Ophthalmology

Volumn 43, Issue 6 SUPPL., 1999, Pages

  Hayreh, Sohan Singh ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Ambulatory blood pressure monitoring; Anterior ischemic optic neuropathy; Blood pressure; Glaucoma; Glaucomatous optic neuropathy; Intraocular pressure; Nocturnal arterial hypotension; Normal tension glaucoma; Optic nerve head ischemia; Primary open angle glaucoma

Indexed keywords

AGE; ANIMAL EXPERIMENT; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; GLAUCOMA; HUMAN; HYPOTENSION; INTRAOCULAR PRESSURE; ISCHEMIC OPTIC NEUROPATHY; MAJOR CLINICAL STUDY; NIGHT; NONHUMAN; OPTIC NERVE DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RHESUS MONKEY;

AGE FACTORS; ANIMALS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; OPTIC NEUROPATHY, ISCHEMIC; PROGNOSIS; RISK FACTORS;

EID: 0032796460     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(99)00018-1     Document Type: Conference Paper

References (133)

1. Anderson DR: Autoregulation in glaucoma, in Drance SM (ed): International Symposium on Glaucoma, Ocular Blood Flow, and Drug Treatment, 1990, Seville, Spain. Baltimore, Williams & Wilkins, 1992, pp 82-89.
2. Armaly M.F. Lessons to be learned from the collaborative glaucoma study. Surv Ophthalmol. 25:1980;139-144.
3. Armaly M.F., Krueger D.E., Maunder L.et al. Biostatistical analysis of the collaborative glaucoma study. Summary of the risk factors for glaucomatous visual-field defects Arch Ophthalmol. 98:1980;2163-2171.
4. Bailliart P. La pression artérielle retinienne. Ann Oculist. 165:1928;321-348.
5. Bailliart P: Les relations entre la pression artérielle et la tension oculaire. Bull Soc Ophtalmol Paris 712-716, 1929.
6. Bailliart P. Considerations cliniques sur I'excavation atrophique du nerf optique sans hypertension oculaire. Bull Soc Ophtalmol Fr. 46:1933;407-409.
7. Béchetoille A., Bresson-Dumont H. Diurnal and nocturnal blood pressure drops in patients with focal ischemic glaucoma. Graefes Arch Clin Exp Ophthalmol. 232:1994;675-679.
8. Best F. Die Augensymptome bei den Zirkulationsstörungen des Gehirns. Schieck F., Bruckner A. Kurzes Handbuch der Ophthalmologie, Vol 6. 1931;545-546 Springer, Berlin.
9. Borhani N.O., Mercuri M., Borhani P.A.et al. Final outcome results of the multicenter isradipine diuretic atherosclerosis study (MIDAS). A randomized controlled trial JAMA. 276:1996;785-791.
10. Bose S., Piltz J.R., Breton M.E. Nimodipine, a centrally active calcium antagonist, exerts a beneficial effect on contrast sensitivity in patients with normal-tension glaucoma and in control subjects. Ophthalmology. 102:1995;1236-1241.
11. Bresson-Dumont H., Bechetoille A. Rôle de la tension artérielle dans l'évolutivité des lésions glaucomateuses. J Fr Ophtalmol. 19:1996;435-442.
12. Carter C.J., Brooks D.E., Doyle D.L., Drance S.M. Investigations into a vascular etiology for low-tension glaucoma. Ophthalmology. 97:1990;49-55.
13. Chobanian A.V. Calcium channel blockers. lessons learned from MIDAS and other clinical trials JAMA. 276:1996;829-830.
14. Chumbley L.C., Brubaker R.F. Low-tension glaucoma. Am J Ophthalmol. 81:1976;761-767.
15. Daling J.R. Calcium channel blockers and cancer. is an association biologically plausible? Am J Hypertens. 9:1996;713-714.
16. Demailly P., Cambien F., Plouin P.F.et al. Do patients with low tension glaucoma have particular cardiovascular characteristics? Ophthalmologica. 188:1984;65-75.
17. Drance S.M. Some factors in the production of low tension glaucoma. Br J Ophthalmol. 56:1972;229-242.
18. Drance S.M. Some factors involved in the production of low tension glaucoma. Cant J.S. The Optic Nerve. 1972;339-366 Kimpton, London.
19. Drance S.M., Douglas G.R., Wijsman K.et al. Response of blood flow to warm and cold in normal and low-tension glaucoma patients. Am J Ophthalmol. 105:1988;35-39.
20. Drance S.M., Morgan R.W., Sweeney V.P. Shock-induced optic neuropathy. A cause of nonprogressive glaucoma N Engl J Med. 288:1973;392-395.
21. Drance S.M., Schulzer M., Douglas G.R., Sweeney V.P. Use of discriminant analysis. II. Identification of persons with glaucomatous visual field defects Arch Ophthalmol. 96:1978;1571-1573.
22. Drance S.M., Sweeney V.P., Morgan R.W., Feldman F. Studies of factors involved in the production of low tension glaucoma. Arch Ophthalmol. 89:1973;457-465.
23. Drance S.M., Wheeler C., Pattullo M. Uniocular open-angle glaucoma. Am J Ophthalmol. 65:1968;891-902.
24. Ekbom K.A. Scotoma due to arterial hypotension. Acta Ophthalmol. 51:1973;375-382.
25. Elwyn H. Calcified carotid artery with atrophy of the optic nerve, cupping, and low tension. Arch Ophthalmol. 24:1940;476-478.
26. Floras J.S. Antihypertensive treatment, myocardial infarction, and nocturnal myocardial ischaemia. Lancet. 29:1988;994-996.
27. Floras J., Sleight P. Ambulatory monitoring of blood pressure. Sleight P., Jones J.V. Scientific Foundation of Cardiology. 1983;155-164 Heinemann, London.
28. Francois J. The glaucomatous optic disk. Isr J Med Sci. 8:1972;1373-1381.
29. Francois J., Neetens A. The deterioration of the visual field in glaucoma and the blood pressure. Doc Ophthalmol. 28:1970;70-132.
30. Friedland S., Kaplan S., Lahav M., Shapiro A. Proptosis and periorbital edema due to diltiazem treatment. Arch Ophthalmol. 111:1993;1027-1028.
31. Furburg C.D., Psaty B.M., Meyer J.V. Nifedipine. dose-related increase in mortality in patients with coronary heart disease Circulation. 92:1995;1326-1331.
32. Gallois J: Glaucome chronique et abaissement de la tension artérielle generale. Bull Soc Ophtalmol Paris 110-112, 1933.
33. Gaspar A.Z., Flammer J., Hendrickson P. Influence of nifedipine on the visual fields of patients with optic-nerve-head diseases. Eur J Ophthalmol. 4:1994;24-28.
34. Gaspar A.Z., Gasser P., Flammer J. The influence of magnesium on visual field and peripheral vasospasm in glaucoma. Ophthalmologica. 209:1995;11-13.
35. Gasser P., Flammer J. Influence of vasospasm on visual function. Doc Ophthalmol. 66:1987;3-18.
36. Gasser P., Flammer J., Guthauser U., Niesel P. Bedeutung des vasospastischen syndroms in der Augenheilkunde. Klin Monatsbl Augenheilkd. 188:1986;398-399.
37. Gasser P., Flammer J., Guthauser U., Mahler F. Do vasospasms provoke ocular diseases? Angiology. 41:1990;213-220.
38. Gasteiger H. Uber den Wert der Rontgendiagnose bei unklaren Sehnervenleiden. Klin Monatsbl Augenheilkd. 96:1936;589-601.
39. Ghislanzoni R., Ramella G. Gli elementi radiologici nella diagnosi di sclerosi dei vasi della base cerebrale in rapporto sopratutto colle alterazioni del nerve ottico. Min Med. 50:1959;1546-1549.
40. Goldberg I., Hollows F.C., Kass M.A., Becker B. Systemic factors in patients with low-tension glaucoma. Br J Ophthalmol. 65:1981;56-62.
41. Graham S.L., Drance S.M., Wijsman K.et al. Ambulatory blood pressure monitoring in glaucoma. Ophthalmology. 102:1995;61-69.
42. Gramer E., Leydhecker W. Glaucom ohne hochdruck. eine klinische studie Klin Monatsbl Augenheilkd. 186:1985;262-267.
43. Guthauser U., Flammer J., Mahler F. The relationship between digital and ocular vasospasm. Graefes Arch Clin Exp Ophthalmol. 226:1988;224-226.
44. Haas J.S. Low tension glaucoma. Trans Pac Coast Otoophthalmol Soc Annu Meet. 43:1962;153-160.
45. Harrington D.O. The pathogenesis of glaucoma field. Arch Ophthalmol. 47:1959;177-185.
46. Harris A., Evans D.W., Cantor L.B., Martin B. Hemodynamic and visual function effects of oral nifedipine in patients with normal-tension glaucoma. Am J Ophthalmol. 124:1997;296-302.
47. Hayreh S.S. Anterior ischaemic optic neuropathy. I. Terminology and pathogenesis Br J Ophthalmol. 58:1974;955-963.
48. Hayreh S.S. Factors determining the glaucomatous optic nerve head damage. Krieglstein G.K. Glaucoma Update III. 1987;40-46 Springer-Verlag, Heidelberg.
49. Hayreh SS: Vascular factors in the pathogenesis of glaucomatous optic neuropathy, in Drance SM (ed): International Symposium on Glaucoma, Ocular Blood Flow, and Drug Treatment, 1990, Seville, Spain. Philadelphia, Williams & Wilkins, 1992, pp 33-41.
50. Hayreh S.S. Die Bedeutung vasculärer Faktoren in der Pathogenese des Glaukomschadens. Pillunat L.-E., Stodtmeister R. Das Glaukom, 1990, Ulm, Germany. 1993;34-58 Springer-Verlag, Heidelberg.
51. Hayreh S.S. Progress in the understanding of the vascular etiology of glaucoma. Curr Opin Ophthalmol. 5:1994;26-35.
52. Hayreh S.S. Duke-Elder Lecture. Systemic arterial blood pressure and the eye Eye. 10:1996;5-28.
53. Hayreh S.S. Acute ischemic disorders of the optic nerve. Pathogenesis, clinical manifestations and management Ophthalmol Clin North Am. 9:1996;407-442.
54. Hayreh S.S. Evaluation of optic nerve head circulation. Review of the methods used J Glaucoma. 6:1997;319-330.
55. Hayreh S.S. Factors influencing blood flow in the optic nerve head. J Glaucoma. 6:1997;412-425.
56. Hayreh S.S., Edwards J. Ophthalmic arterial and venous pressures. Effects of acute intracranial hypertension Br J Ophthalmol. 55:1971;649-663.
57. Hayreh S.S., Jonas J.B., Zimmerman M.B. Parapapillary chorioretinal atrophy in chronic high-pressure experimental glaucoma in rhesus monkeys. Invest Ophthalmol Vis Sci. 39:1998;2296-2303.
58. Hayreh S.S., Pe'er J., Zimmerman M.B. Morphologic changes in chronic high-pressure experimental glaucoma in rhesus monkeys. J Glaucoma. 8:1999;56-71.
59. Hayreh S.S., Piegors D.J., Heistad D.D. Serotonin induced constriction of ocular arteries in atherosclerotic monkeys. Implications for ischemic disorders of retina and optic nerve head Arch Ophthalmol. 115:1997;220-228.
60. Hayreh S.S., Podhajsky P.A., Zimmerman B. Non-arteritic anterior ischemic optic neuropathy. Time of onset of visual loss Am J Ophthalmol. 124:1997;641-647.
61. Hayreh S.S., Podhajsky P.A., Zimmerman B. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica. 213:1999;76-96.
62. Hayreh S.S., Revie H.I.S., Edwards J. Vasogenic origin of visual field defects and optic nerve changes in glaucoma. Br J Ophthalmol. 54:1970;461-472.
63. Hayreh S.S., Servais G.E., Virdi P.S.et al. Fundus lesions in malignant hypertension. III. Arterial blood pressure, biochemical, and fundus changes Ophthalmology. 93:1986;45-59.
64. Hayreh S.S., Zimmerman M.B., Podhajsky P., Alward W.L.M. Nocturnal arterial hypotension and its role in optic nerve and ocular ischemic disorders. Am J Ophthalmol. 117:1994;603-624.
65. Hayreh S.S., Zimmerman M.B., Podhajsky P., Alward W.L.M. Nonarteritic anterior ischemic optic neuropathy. Role of nocturnal arterial hypotension Arch Ophthalmol. 115:1997;942-943.
66. Heilmann K. Augendruck, Blutdruck und Glaukomschaden. 1972;Enke, Stuttgart.
67. Horino S., Riva C.E., Petrig B.L. Intravenous nicardipine in cats increases optic nerve head but not retinal blood flow. Invest Ophthalmol Vis Sci. 33:1992;2885-2890.
68. Johnson D.G., Drance S.M. Some studies on the circulation in patients with advanced open angle glaucoma. Can J Ophthalmol. 3:1968;149-153.
69. Joist J.H., Lichtenfeld P., Mandell A.I., Kolker A.E. Platelet function, blood coagulability, and fibrinolysis in patients with low tension glaucoma. Arch Ophthalmol. 94:1976;1893-1895.
70. Jonas J.B., Fernández M.C., Naumann G.O.H. Glaucomatous parapapillary atrophy. Occurrence and correlations Arch Ophthalmol. 110:1992;214-222.
71. Jonas J.B., Gusek G.C., Fernández M.C. Correlation of the blind spot size to the area of the optic disc and parapapillary atrophy. Am J Ophthalmol. 111:1991;559-565.
72. Jonas J.B., Königsreuther K.A., Naumann G.O.H. Optic disc histomorphometry in normal and glaucomatous eyes. II. Parapapillary region Graefes Arch Clin Exp Ophthal. 230:1992;134-139.
73. Jonas J.B., Naumann G.O.H. Parapapillary chorio-retinal atrophy in normal and glaucoma eyes. II. Correlations Invest Ophthalmol Vis Sci. 30:1989;919-926.
74. Jonas J.B., Nguyen X.N., Gusek G.C., Naumann G.O.H. The parapapillary chorio-retinal atrophy in normal and glaucoma eyes. I. Morphometric data Invest Ophthalmol Vis Sci. 30:1989;908-918.
75. Kaiser H.J., Flammer J., Burckhardt D. Silent myocardial ischemia in glaucoma patients. Ophthalmologica. 207:1993;6-8.
76. Kaiser H.J., Flammer J., Graf T., Stümfig D. Systemic blood pressure in glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 231:1993;677-680.
77. Kanellopoulos A.J., Erickson K.A., Netland P.A. Systemic calcium channel blockers and glaucoma. J Glaucoma. 5:1996;357-362.
78. Kario K., Imiya M., Ohat Y., Shimada K. Gastrointestinal bleeding induced by amlodipine. J Hum Hypertens. 9:1995;206-207.
79. 2+-antagonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophhalmol. 227:1989;408-412.
80. Knapp A. Association of sclerosis of the cerebral basal vessels with optic atrophy and cupping. Report of 10 cases Arch Ophthalmol. 8:1932;637-648.
81. Knapp A. Course in certain cases of atrophy of the optic nerve with cupping and low tension. Arch Ophthalmol. 23:1940;41-47.
82. Kubota T., Jonas J.B., Naumann G.O.H. Direct clinico-histological correlation of parapapillary chorioretinal atrophy. Br J Ophthalmol. 77:1993;103-106.
83. Laatikainen L. Fluorescein angiographic studies of the peripapillary and perilimbal regions in simple, capsular and low-tension glaucoma. Acta Ophthalmol Suppl. 111:1971;3-83.
84. Landau K., Winterkorn J.M.S., Mailloux L.U.et al. 24-Hour blood pressure monitoring in patients with anterior ischemic optic neuropathy. Arch Ophthalmol. 114:1996;570-575.
85. Langham M.E. Ocular blood flow and visual loss in glaucomatous eyes. Krieglstein G.K. Glaucoma Update III. 1987;58-66 Springer-Verlag, Heidelberg.
86. Lauber H. Treatment of atrophy of the optic nerve. Arch Ophthalmol. 16:1936;555-568.
87. Leighton D.A., Phillips C. Systemic blood pressure in open angle glaucoma, low tension glaucoma, and the normal eye. Br J Ophthalmol. 56:1972;447-453.
88. Leske M.C. The epidemiology of open-angle glaucoma. A review Am J Epidemiol. 118:1983;166-191.
89. Leske M.C., Podgor M.J. Intraocular pressure, cardiovascular risk variables, and visual field defects. Am J Epidemiol. 118:1983;280-287.
90. Levene R.Z. Low tension glaucoma. a critical review and new material Surv Ophthalmol. 24:1980;621-664.
91. Lewis R.A., Vijayan N., Watson C.et al. Visual field loss in migraine. Ophthalmology. 96:1989;321-326.
92. Liu S., Araujo S.V., Spaeth G.L.et al. Lack of effect of calcium channel blockers on open-angle glaucoma. J Glaucoma. 5:1996;187-190.
93. Loebl M., Schwartz B. Fluorescein angiographic defects of the optic disc in ocular hypertension. Arch Ophthalmol. 95:1977;1980-1984.
94. Lumme P., Tuulonen A., Airaksinen P.J., Alanko H.I., Neuroretinal rim area in low tension glaucoma effect of nifedipine and acetazolamide compared to no treatment. Acta Ophthalmol. 69:1991;293-298.
95. Magitot A. Glaucomes sans hypertension. Ann Oculist. 175:1938;349-368.
96. Magnus J.A. A case of pseudo-glaucoma. Br J Ophthalmol. 31:1947;692-696.
97. McLean J.M. Management of the primary glaucomas. Am J Ophthalmol. 44:1957;323-334.
98. McLean J.M., Ray B.S. Soft glaucoma and calcification of the internal carotid arteries. Arch Ophthalmol. 38:1947;154-158.
99. Meyer J. Un cas d'atrophie du nerf optique avec excavation et sans hypertension. Arch Ophtalmol. 45:1928;46-50.
100. Meyer J.H., Brandi-Dohrn J., Funk J. Twenty four hour blood pressure monitoring in normal tension glaucoma. Br J Ophthalmol. 80:1996;864-867.
101. Miller S. The enigma of glaucoma simplex. Trans Ophthalmol Soc U K. 92:1972;561-584.
102. Netland P.A., Chaturvedi N., Dreyer E.B. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol. 115:1993;608-613.
103. O'Brien C., Butt Z., Ludlam C., Detkova P. Activation of the coagulation cascade in untreated primary open-angle glaucoma. Ophthalmology. 104:1997;725-730.
104. Pahor M., Guralnik J.M., Furberg C.D.et al. Risk of gastrointestinal hemorrhage with calcium antagonists in hypertensive patients over 67 years old. Lancet. 347:1996;1061-1065.
105. Pahor M., Guralnik J.M., Salive M.E.et al. Do calcium channel blockers increase the risk of cancer? Am J Hypertens. 9:1996;695-699.
106. Peräsalo R., Raitta C., Peräsalo J. Optic nerve fiber loss in relation to atrial fibrillation and blood pressure. Int Ophthalmol. 16:1992;259-263.
107. Phelps C.D., Corbett J.J. Migraine and low-tension glaucoma. A case-control study Invest Ophthalmol Vis Sci. 26:1985;1105-1108.
108. Psaty B.M., Heckbert S.R., Koepsell T.D.et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 274:1995;620-625.
109. Redslob E. Glaucome sans hypertension et excavation glaucomateuse. Ann Oculist. 177:1941;323-340.
110. Reese A.B., McGavic J.S. Relation of field contraction to blood pressure in chronic primary glaucoma. Arch Ophthalmol. 27:1942;845-850.
111. Richler M., Werner E.B., Thomas D. Risk factors for progression of visual field defects in medically treated patients with glaucoma. Can J Ophthalmol. 17:1982;245-248.
112. Rouhiainen H.J., Teräsvirta M.E. Hemodynamic variables in progressive and non-progressive low tension glaucoma. Acta Ophthalmol. 68:1990;34-36.
113. Sachsenweger R. Der Einfluss des Bluthochdruckes auf die Prognose des Glaukoms. Klin Monatsbl Augenheilkd. 142:1963;625-633.
114. Sawada A., Kitazawa Y., Yamamoto T.et al. Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma. Ophthalmology. 103:1996;283-288.
115. Schmidt K.G., von Ruckmann A., Geyer O., Mittag T.W. Einfluss des Nifedipins auf die okulare Pulsamplitude bei Normaldruckglaukom. Klin Monatsbl Augenheilkd. 210:1997;355-359.
116. Schulzer M., Drance S.M., Carter C.J.et al. Biostatiscal evidence for two distinct chronic open angle glaucoma populations. Br J Ophthalmol. 74:1990;196-200.
117. Shiose Y., Itoh T., Komuro K., Amano M. Prevalence and background of ocular hypertension and low tension glaucoma. Acta Soc Ophthalmol Jpn. 88:1984;806-813.
118. Siegert P. Die ursachliche Bedeutung einer Verkalkung oder Thrombose der Carotis interna für Funktionsstorungen des Auges. Albrecht von Graefes Arch Ophthalmol. 138:1938;798-844.
119. Sjögren H. A study in pseudoglaucoma (glaucoma without hypertension). Acta Ophthalmol. 24:1946;239-294.
120. Sobanski J. Der intraokulare Druck und sein Einfluss auf die Zirkulation in der Netzhaut. Klin Oczna. 13:1935;214-237.
121. Sobanski J. Der Augendruck und sein Einfluss auf den Blutkreislauf in der Netzhaut. Albrecht von Graefes Arch Ophthalmol. 185:1936;383-400.
122. Spaeth G.L. Fluorescein angiography. its contributions towards understanding the mechanisms of visual loss in glaucoma Trans Am Ophthalmol Soc. 73:1975;491-553.
123. Thiel R. Glaukom ohne Hochdruck. Ber Dtsch Ophthalmol Gesellsch. 48:1930;133-136.
124. Tielsch J.M., Katz J., Sommer A.et al. Hypertension, perfusion pressure and primary open angle glaucoma. Arch Ophthalmol. 113:1995;216-221.
125. von Stief A. Zur Histopathologie des Sehnerven bei der Arteriosklerose und bei der senilen Demenz. Z Augenheilkd. 70:1930;41-52.
126. Wagenknecht L., Furberg C.D., Hammon J.et al. Surgical bleeding. an unexpected effect of calcium antagonists Br Med J. 310:1995;776-777.
127. Walker W.M., Walton K.W., Magnani H.N.et al. Glaucoma and ischaemic vascular disease risk factors. Trans Ophthalmol Soc U K. 96:1976;237-240.
128. Weekers R. Le glaucome incomplet. Contribution a l'étude du glaucome sans hypertension Ophthalmologica. 104:1942;316-331.
129. Weinstein P. Data concerning the pseudoglaucoma. Acta Ophthalmol. 41:1963;275-278.
130. Weinstock F.J. Ophthalmic hazards of hypotensive drugs. JAMA. 224:1973;1039.
131. Wilson M.R., Hertzmark E., Walker A.M.et al. A case-control study of risk factors in open angle glaucoma. Arch Ophthalmol. 105:1987;1066-1071.
132. Winder A.F., Paterson G., Miller S.J.H. Biochemical abnormalities associated with ocular hypertension and low tension glaucoma. Trans Ophthalmol Soc U K. 94:1974;518-524.
133. Yu D.-Y., Alder V.A., Su E.-N., Cringle S.J. Relaxation effects of diltiazem, verapamil, and tolazoline on isolated cat ophthalmociliary artery. Exp Eye Res. 55:1992;757-766.